Just what the doctor order: new acting CEO and $ in the bankRich Geruson is a gift to a tech startup about to launch manufacturing into the global market. His resume is stellar. Zero fail, 100% out of the ball park success. He takes companies with issues, creatively fixes them, and puts their products, be them the BIOS in our beloved devices, Voice Recognition Software everyone used everyday in their smartphone while they drive, or imaging devices businesses use across the planet. What makes you think his track record will suddenly stop with NXO? He will undoubtedly create increasing global revenues with the tech available to him, and he will do it fast. That is what he does.
Maritimer lies on this board, ignore him. I have been to the Edmonton Lab and seen two prototypes with my own eyes. It is real, and yes they work as published. No hoax here; we are not being duped,and neither has Rich Geruson. Hello!
Rich Geruson does not come cheap, and as CEOs do, he comes with the ability to raise capital. If he is to make a difference, he needs cash to make good on promisses made to shareholders. He has no magic wand, he needs cash to timely make it to market. For what he brings to the table, he easily could have taken 15% of the company or more. He will undoubtedly get options, but at these prices, his institutional followers are willing to pay for their peice of the pie while private placement money reserved for them puts money in the NXOs bank for Rich to multiply.
An extra $5 million in the bank will put the projects on steriods and with a new leader on the board, ensure success of the company: just what the doctor ordered!